Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navid Jallali

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Melanoma Management|February 8, 2021
Increase of sentinel lymph node melanoma staging in The Netherlands: still room and need for further improvementHarmanjit Singh, Anjelli Wignakumar, Georgina J Williams, et al.
Journal of Biomedical Optics|June 21, 2019
Pervasive wearable device for free tissue transfer monitoring based on advanced data analysis: clinical study reportMelissa Berthelot, Francis Patrick Henry, Judith Hunter, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|September 19, 2020
The feasibility and safety of immediate breast reconstruction in the COVID-19 eraNavid Jallali, Judith E Hunter, Francis P Henry, et al.
Annals of Surgical Oncology|July 19, 2018
Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA ComputationsTania Samantha de Silva, Victoria Rose Russell, Francis Patrick Henry, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
The Lancet. Oncology|April 10, 2022
Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility studyPaul T R Thiruchelvam, Daniel R Leff, Amy R Godden, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Melanoma Management|February 8, 2021
Increase of sentinel lymph node melanoma staging in The Netherlands: still room and need for further improvementHarmanjit Singh, Anjelli Wignakumar, Georgina J Williams, et al.
Journal of Biomedical Optics|June 21, 2019
Pervasive wearable device for free tissue transfer monitoring based on advanced data analysis: clinical study reportMelissa Berthelot, Francis Patrick Henry, Judith Hunter, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|September 19, 2020
The feasibility and safety of immediate breast reconstruction in the COVID-19 eraNavid Jallali, Judith E Hunter, Francis P Henry, et al.
Annals of Surgical Oncology|July 19, 2018
Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA ComputationsTania Samantha de Silva, Victoria Rose Russell, Francis Patrick Henry, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
The Lancet. Oncology|April 10, 2022
Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility studyPaul T R Thiruchelvam, Daniel R Leff, Amy R Godden, et al.
Pageof 3